3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Motor Activity
6
Neoplasms
5
Pancreatic Neoplasms
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Fatigue
1
Disease
1
Colonic Neoplasms
1
Breast Neoplasms
1
Interventions
Nivolumab
19
pembrolizumab
17
Ipilimumab
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
7
CTLA-4 Antigen
6
binimetinib
5
Opdualag
5
trametinib
4
relatlimab
4
dabrafenib
3
Standard of Care
3
Paclitaxel
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Blood Specimen Collection
3
ulixertinib
2
sargramostim
2
lenvatinib
2
fludarabine phosphate
2
fludarabine
2
encorafenib
2
capivasertib
2
cabozantinib
2
atezolizumab
2
aldesleukin
2
X-Rays
2
Taxes
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Exercise
×
30 days
×
Clear all
No trials found.